Friday, April 20, 2012

As Mobile Applications Cross Over Into FDA Regulatory Territory, New Frictions Emerge


Updated April 9, 2024

Links in the original post broke.

You might also be interested in:

---  the original post follows below  ---

We want mobile apps, and it's going to be a very tough regulatory balancing act . . .

As Mobile Applications Cross Over Into FDA Regulatory Territory, New Frictions Emerge - RAPS - News - Article View:

"The emerging clash follows FDA’s promulgation of draft guidance in July 2011, when it proposed some basic regulatory principles for mobile medical application developers. Those principles include which apps would—and which apps would not—be regulated under FDA’s authority, FDA’s regulatory approach toward those applications, general categories for mobile medical applications and corresponding levels of anticipated FDA regulation, and regulatory requirements for developers and manufacturers of applications.

“That seemed reasonable enough to the traditional medical-device industry, which is well-versed in the ways of the FDA,” explained Politico. “But the requirements — data on effectiveness, possibly clinical trials — have gobsmacked some software developers who are used to working in the fast-paced, relatively unregulated wilds of the Internet.”"

'via Blog this'

Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

SkillsPlus Intl Inc. - GMP and QSR Compliance Training Experts
SkillsPlus Intl Info Blog
The Health, Drug, Prescription, and GMP Supersite Gift Store 

No comments:

From SkillsPlus International Inc.